Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 64.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.76 | 52 Week High | $3.48 | |||
| Open | $64.76 | 52 Week Low | $0.80 | |||
| Day High | $64.76 | P/E | N/A | |||
| Day Low | $64.76 | EPS | $-1.54 | |||
| Volume | 102 | |||||
| (NASDAQ: ZYME) | Delayed: 28.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.37 | 52 Week High | $ | |||
| Open | $28.37 | 52 Week Low | $ | |||
| Day High | $28.37 | P/E | N/A | |||
| Day Low | $28.37 | EPS | $ | |||
| Volume | 15 | |||||
